CTRI/2024/02/062575已完成不适用
Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy human subjects
Transformative Learning Solutions Pvt Ltd1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2024年2月19日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- To determine the potential irritation of the test
研究概览
简要总结
The study consists of single application of sample on the upper back of human participants, under occlusive patch for the duration of 24 hour of exposure. After removal of patches post 24 hr. The assessment of skin reaction needs to be evaluated subjectively using the Draize Scale 24hour removal of patches. Follow up reactions will be done one week thereafter to confirm recovery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Subjects in age group
- •65 years (both the ages inclusive).
- •Healthy male & female subjects with skin types as defined in the population details under appendix
- •Subjects in good health condition as per the medical screening criteria with no disease state or physical condition that the Investigator believes could interfere with the interpretation of the data.
- •Subject able to read, understand and sign an appropriate informed consent form indicating her willingness to participate.
- •Subjects willing to give a voluntary written informed consent.
- •Subjects willing to maintain the patch test in position for 24 hours.
- •Subject having not participated in a similar investigation in the past two weeks.
- •Subjects willing to come for regular follow up visits.
- •Subjects ready to follow instructions during the study period.
排除标准
- •Subjects with infection, allergy on the tested area.
- •Subjects with skin allergy, antecedents or atopic subjects.
- •Athletes and subjects with history of excessive sweating.
- •Subjects with cutaneous disease which may influence the study result.
- •Subjects on oral corticosteroid.
- •Subjects participating in any other cosmetic or therapeutic trial.
- •Subjects who are currently pregnant or lactating or planning to become pregnant in the period of study.
- •Subjects with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
- •More than one subject selected or participating from one family or household.
- •Subjects working with MSCR.
结局指标
主要结局
To determine the potential irritation of the test
时间窗: 0 h, 24 h, 7 days
formulation on topical application in skin type
时间窗: 0 h, 24 h, 7 days
human volunteers under controlled patch study
时间窗: 0 h, 24 h, 7 days
conditions in a PIPT test.
时间窗: 0 h, 24 h, 7 days
次要结局
- NA(NA)
研究者
Dr Navya Annam
MS Clinical Research
研究点 (1)
Loading locations...
相似试验
已完成
2/3 期
Safety test for the test products by patch test method for 24 hours under complete occlusion on healthy human subjectsCTRI/2024/05/068029Innovantase research and development services24
已完成
2/3 期
Testing the safety of test products by placing patches on healthy volunteers for 24 hours, keeping the patches covered completely.CTRI/2024/10/075037Transformative Learning Solution Pvt. Ltd.24
已完成
2/3 期
safety check of test products using 24-hour patch testCTRI/2025/01/079417Transformative Learning Solution Pvt. Ltd.24
已完成
不适用
Primary Irritation Patch Test (i.e safety testing) for Normal Skin (Single Application 24-hour Occlusion)CTRI/2024/01/061466Transformative Learning Solutions Pvt Ltd.26
已完成
不适用
Evaluation of Skin Safety of a Nano Urea emulsion Through 24-Hour Patch Testing in Healthy Individuals.CTRI/2024/11/077114CROM Clinical Research and Medical Tourism Pvt. Ltd. Division Nano Agro Technologies60